Home › Compare › BPSR vs BTI

BPSR vs BTI: Dividend Comparison 2026

BPSR yields 3333.33% · BTI yields 5.40%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BPSR wins by $1244041712890.36M in total portfolio value
10 years
BPSR
BPSR
● Live price
3333.33%
Share price
$0.06
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1244041712890.40M
Annual income
$1,174,716,366,071,938,000.00
Full BPSR calculator →
BTI
BTI
● Live price
5.40%
Share price
$58.26
Annual div
$3.15
5Y div CAGR
11.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.8K
Annual income
$2,802.29
Full BTI calculator →

Portfolio growth — BPSR vs BTI

📍 BPSR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBPSRBTI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BPSR + BTI cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
BPSR pays
BTI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BPSR
Annual income on $10K today (after 15% tax)
$283,333.33/yr
After 10yr DRIP, annual income (after tax)
$998,508,911,161,147,300.00/yr
BTI
Annual income on $10K today (after 15% tax)
$459.05/yr
After 10yr DRIP, annual income (after tax)
$2,381.95/yr
At 15% tax rate, BPSR beats the other by $998,508,911,161,144,800.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BPSR + BTI for your $10,000?

BPSR: 50%BTI: 50%
100% BTI50/50100% BPSR
Portfolio after 10yr
$622020856445.22M
Annual income
$587,358,183,035,970,400.00/yr
Blended yield
94.43%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

BPSR
No analyst data
BTI
Analyst Ratings
12
Buy
4
Hold
2
Sell
Consensus: Buy
Price Target
$40.00
-31.3% upside vs current
Range: $40.00 — $40.00
Altman Z
2.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BPSR buys
0
BTI buys
0
No recent congressional trades found for BPSR or BTI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBPSRBTI
Forward yield3333.33% ✓5.40%
Annual dividend / share$2.00$3.15 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%11.3% ✓
Portfolio after 10y$1244041712890.40M ✓$37.8K
Annual income after 10y$1,174,716,366,071,938,000.00 ✓$2,802.29
Total dividends collected$1239274250481.68M ✓$14.4K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: BPSR vs BTI ($10,000, DRIP)

YearBPSR PortfolioBPSR Income/yrBTI PortfolioBTI Income/yrGap
1← crossover$344,033$333,333.33$11,301$601.08+$332.7K → BPSR
2$11,085,665$10,717,549.33$12,799$706.58+$11.07M → BPSR
3$334,616,633$322,754,971.08$14,527$832.38+$334.60M → BPSR
4$9,462,934,690$9,104,894,892.71$16,527$982.75+$9462.92M → BPSR
5$250,766,259,005$240,640,918,887.41$18,846$1,162.95+$250766.24M → BPSR
6$6,228,082,462,189$5,959,762,565,053.11$21,545$1,379.49+$6228082.44M → BPSR
7$144,998,525,500,125$138,334,477,265,582.72$24,694$1,640.41+$144998525.48M → BPSR
8$3,165,074,899,913,431$3,009,926,477,628,297.00$28,378$1,955.69+$3165074899.89M → BPSR
9$64,790,043,755,570,470$61,403,413,612,663,110.00$32,702$2,337.79+$64790043755.54M → BPSR
10$1,244,041,712,890,398,500$1,174,716,366,071,938,000.00$37,794$2,802.29+$1244041712890.36M → BPSR

BPSR vs BTI: Complete Analysis 2026

BPSR — Stock

Organicell Regenerative Medicine, Inc. processes, distributes, and supplies biologically processed cellular and tissue-based products in the United States. The company was formerly known as Biotech Products Services and Research, Inc. and changed its name to Organicell Regenerative Medicine, Inc. in June 2018. Organicell Regenerative Medicine, Inc. has an agreement with Regenerative Care Network to study potential therapeutic benefits of Zofin for patients with heart failure. Organicell Regenerative Medicine, Inc. was founded in 2011 and is headquartered in Miami, Florida.

Full BPSR Calculator →

BTI — Consumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →
📬

Get this BPSR vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BPSR vs SCHDBPSR vs JEPIBPSR vs OBPSR vs KOBPSR vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.